Characteristics, treatment patterns and outcomes of patients with small cell lung cancer-A retrospective single institution analysis

Lung Cancer

Volumn 71, Issue 3, 2011, Pages 363-366

  Hermes, Andreas ^a   Waschki, Benjamin ^a   Gatzemeier, Ulrich ^a   Reck, Martin ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Treatment of small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IPILIMUMAB; MESNA; PACLITAXEL; PEMETREXED; TOPOTECAN; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FATIGUE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKULL IRRADIATION; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79851507895     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.06.003     Document Type: Article

References (16)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2008. CA Cancer J Clin 2008, 58:71-96.
2. Krebs in Deutschland: Arbeitsgem. Bevölkerungsbezogener Krebsregister in Deutschland und RKI; 2004.
3. Govindan R., Page N., Morgenstern D., et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol 2006, 24:4539-4544.
4. Stanley K.E. Prognostic factors in lung cancer. Lung cancer 1985, 41-66. Churchill Livingstone, New York, NY. J. Aisner (Ed.).
5. World Health Organization WHO handbook for reporting results of cancer treatment (WHO Offdet Publication No. 48) 1979, World Health Organization, Geneva, Switzerland.
6. Stahel R.A., Ginsberg R., Havemann K., et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989, 5:119-126.
7. Gatzemeier U., Pawel Jv, Laumen R., Hossfeld D.K., Neuhauss R., Reck M., Lenaz L Carboplatin/etoposide/vincristine therapy in small cell lung cancer. Oncology 1992, 49(1):25-33.
8. Simon G.R., Turrisi A. American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl. 3):324S-339S.
9. Thatcher N., Faivre-Finn C., Lorigan P. Management of small-cell lung cancer. Ann Oncol 2005, 16(Suppl. 2):ii235-ii239.
10. Sheperd F.A., Crowley J., van Houte J., et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
11. Noda K., Nishiwaki Y., Kawahara M., et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small lung cancer. N Engl J Med 2002, 346:85-91.
12. Hanna N., Bunn P.A., Langer C., et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006, 24:2038-2043.
13. Hermes A., Bergman B., Bremnes R., et al. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial. J Clin Oncol 2008, 26:4261-4267.
14. Lara P.N., Natale R., Crowley J., et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009, 27:2530-2535.
15. Reck M., von Pawel J., Macha, et al. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide and vincristine in patients with small cell lung cancer. J Natl Cancer Inst 2003, 95:1118-1127.
16. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. New Engl J Med 2007, 357:664-672.